These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15526236)

  • 1. Current guidelines in the pharmacological management of chronic heart failure.
    Metra M; Nodari S; Dei Cas L
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S11-6. PubMed ID: 15526236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatment of chronic heart failure according to the 2005 guidelines of the European Society of Cardiology.
    Voors AA; van Veldhuisen DJ
    Minerva Cardioangiol; 2005 Aug; 53(4):233-9. PubMed ID: 16177668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessing guidelines for heart failure.
    Drexler H; Wollert KC
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S28-33. PubMed ID: 15526240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards the better treatment of heart failure.
    Remme WJ
    Eur Heart J; 1998 Oct; 19 Suppl L():L36-42. PubMed ID: 9821008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conclusions on the management of heart failure.
    Swedberg K
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S34-6. PubMed ID: 15526241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New strategies for improving heart failure management: a primary care perspective.
    Basile J
    South Med J; 2001 Feb; 94(2):166-74. PubMed ID: 11235030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objectives of guidelines on heart failure.
    Tavazzi L
    Eur Heart J; 1998 Oct; 19 Suppl L():L33-5. PubMed ID: 9821007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of heart failure progression: current approaches.
    Lechat P
    Eur Heart J; 1998 Feb; 19 Suppl B():B12-8. PubMed ID: 9519347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure.
    Howard PA; Cheng JW; Crouch MA; Colucci VJ; Kalus JS; Spinler SA; Munger M
    Ann Pharmacother; 2006 Sep; 40(9):1607-17. PubMed ID: 16896019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
    Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Circ Heart Fail; 2008 Jul; 1(2):98-106. PubMed ID: 19808279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM
    Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of worsening heart failure: future focus.
    Remme WJ
    Eur Heart J; 1998 Feb; 19 Suppl B():B47-53. PubMed ID: 9519352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
    G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between cardiologists and internists in the management of heart failure. Medical guidelines compared with every-day practice.
    Stawicki S; Roik M; Jasik M; Kosior D; Scisło P; Kochanowski J; Dembe K; Steckiewicz R; Karnafel W; Opolski G
    Kardiol Pol; 2004 Nov; 61(11):431-9; discussion 440-1. PubMed ID: 15883591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines for choosing drugs in chronic heart failure.
    Tabrizchi R
    Vasc Health Risk Manag; 2005; 1(3):171-2. PubMed ID: 17319102
    [No Abstract]   [Full Text] [Related]  

  • 18. Current guidelines for treatment of heart failure: 2006 update.
    Uddin N; Patterson JH
    Pharmacotherapy; 2007 Apr; 27(4 Pt 2):12S-17S. PubMed ID: 17381370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological therapy of chronic heart failure in the elderly].
    Sabbadini G; Di Lenarda A; Metra M; Nodari S; Moretti M; Brentana L; Dei Cas L; Sinagra G
    Ital Heart J; 2004 Dec; 5 Suppl 10():37S-51S. PubMed ID: 15712511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastolic heart failure: state of the science on best treatment practices.
    Reddersen LA; Keen C; Nasir L; Berry D
    J Am Acad Nurse Pract; 2008 Oct; 20(10):506-14. PubMed ID: 19128346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.